Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 29,936 shares at $20.76 ($622K) on 2025-10-01, disclosed to the SEC on 2025-10-03.
Scheduled sale ($622k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.76 | 14,918 | $310K | 49.8% |
| 2 | $20.76 | 14,918 | $310K | 49.8% |
| 3 | $21.08 | 100 | $2K | 0.3% |
| Total | $20.76 avg | 29,936 | $622K | 100% |
| Filing → |
| BBNX | SELL | 2026-06-03 | $84K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $591K | — | Filing → |